Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-20
DOI
10.1038/s41375-020-0854-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-Dose Cytarabine Is Indispensable for the Survival of Children with Myeloid Leukemia of Down Syndrome Despite Negative Minimal Residual Disease Post-Induction
- (2020) Johann K. Hitzler et al. BLOOD
- Need for new thinking: Treatment of relapsed leukemia in children with Down syndrome
- (2019) Karen Rabin et al. PEDIATRIC BLOOD & CANCER
- SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain
- (2019) Paul B. Sinclair et al. LEUKEMIA
- Inherited genetic susceptibility of acute lymphoblastic leukemia in Down syndrome
- (2019) Austin L. Brown et al. BLOOD
- Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen
- (2019) Mirko Kroll et al. HAEMATOLOGICA
- Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome
- (2019) Yasuo Kubota et al. CANCER SCIENCE
- Towards a Better Understanding of Cohesin Mutations in AML
- (2019) Sergi Cuartero et al. Frontiers in Oncology
- Understanding Pre-Leukemia in Trisomy 21 Human HSC and Modeling Progression Towards Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution
- (2019) Elvin Wagenblast et al. BLOOD
- Trisomy 21 Driven Pro-Inflammatory Signalling in Fetal Bone Marrow May Play a Role in Perturbed B-Lymphopoiesis and Acute Lymphoblastic Leukemia of Down Syndrome
- (2019) Sorcha Isabella O'Byrne et al. BLOOD
- Post-Induction Minimal Residual Disease Measured By Flow Cytometry and Deep Sequencing of Mutant GATA1 Are Both Significant Prognostic Factors for Children with Myeloid Leukemia and Down Syndrome: A Nationwide Prospective Study of the Japanese Pediatric Leukemia/Lymphoma Study Group
- (2019) Takashi Taga et al. BLOOD
- Predictive Factors of the Development of Leukemia in Patients with Transient Abnormal Myelopoiesis and Down Syndrome: The Jccg Study JPLSG TAM-10
- (2019) Genki Yamato et al. BLOOD
- National population‐based estimates for major birth defects, 2010–2014
- (2019) Cara T. Mai et al. Birth Defects Research
- Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001
- (2018) Uma H. Athale et al. PEDIATRIC BLOOD & CANCER
- Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells
- (2018) Glenn A. MacLean et al. Scientific Reports
- PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice
- (2018) Laura Jamrog et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic impact of trisomy 21 in follicular lymphoma
- (2018) Takeki Mitsui et al. BRITISH JOURNAL OF HAEMATOLOGY
- A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis
- (2018) Andrew Volk et al. CANCER CELL
- Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression
- (2018) Cody T. Mowery et al. Cell Reports
- Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome
- (2017) Yoann Vial et al. HAEMATOLOGICA
- Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
- (2017) Jasmijn D E de Rooij et al. NATURE GENETICS
- Outcome of acute lymphoblastic leukemia in children with down syndrome—Polish pediatric leukemia and lymphoma study group report
- (2017) Joanna Zawitkowska et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome
- (2017) Omer Schwartzman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors
- (2017) Chunhong Liu et al. Oncotarget
- Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome
- (2017) Yoann Vial et al. HAEMATOLOGICA
- Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States
- (2016) Elizabeth G. Salazar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Low risk of solid tumors in persons with Down syndrome
- (2016) Henrik Hasle et al. GENETICS IN MEDICINE
- Copy-number analysis identified new prognostic marker in acute myeloid leukemia
- (2016) O Nibourel et al. LEUKEMIA
- MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation
- (2016) Y Huang et al. LEUKEMIA
- The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome
- (2016) P Lee et al. LEUKEMIA
- Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004
- (2016) Angela Hassler et al. PEDIATRIC BLOOD & CANCER
- Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic Abnormalities
- (2016) Kimihiko Banno et al. Cell Reports
- Trisomy 21 consistently activates the interferon response
- (2016) Kelly D Sullivan et al. eLife
- The biology of pediatric acute megakaryoblastic leukemia
- (2015) T. A. Gruber et al. BLOOD
- Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia
- (2015) Audrey Derouet et al. BRITISH JOURNAL OF HAEMATOLOGY
- Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation
- (2015) Claire Mazumdar et al. Cell Stem Cell
- Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increasedERGexpression in acute myeloid leukemia
- (2015) Simone Weber et al. GENES CHROMOSOMES & CANCER
- Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus
- (2015) Marta Byrska-Bishop et al. JOURNAL OF CLINICAL INVESTIGATION
- DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
- (2015) Benjamin J. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia
- (2015) K Malinowska-Ozdowy et al. LEUKEMIA
- Genomic landscape of cutaneous T cell lymphoma
- (2015) Jaehyuk Choi et al. NATURE GENETICS
- The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome
- (2015) Ana Carolina da Silva Almeida et al. NATURE GENETICS
- Transient myeloproliferative disorder with partial trisomy 21
- (2015) Takahide Takahashi et al. PEDIATRIC BLOOD & CANCER
- Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan
- (2015) Takashi Taga et al. PEDIATRIC BLOOD & CANCER
- Infection Exposure Is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility
- (2015) A. Martin-Lorenzo et al. Cancer Discovery
- Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome
- (2014) Rita Carsetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children
- (2014) Rintaro Ono et al. EUROPEAN JOURNAL OF PEDIATRICS
- Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias
- (2014) M L Tursky et al. LEUKEMIA
- Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
- (2014) Yilong Li et al. NATURE
- Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
- (2014) Andrew A Lane et al. NATURE GENETICS
- Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome
- (2014) Johann K. Hitzler et al. PEDIATRIC BLOOD & CANCER
- Prognosis and management of acute myeloid leukemia in patients with Down syndrome
- (2014) J Timothy Caldwell et al. Expert Review of Hematology
- Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome
- (2013) Johann K. Hitzler et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder
- (2013) Y. Birger et al. BLOOD
- Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
- (2013) S. I. Nikolaev et al. BLOOD
- Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
- (2013) T. D. Buitenkamp et al. BLOOD
- The calcineurin-NFAT pathway negatively regulates megakaryopoiesis
- (2013) A. Zaslavsky et al. BLOOD
- Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia
- (2013) L. Goldberg et al. BLOOD
- Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes
- (2013) S. Malinge et al. BLOOD
- Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndrome
- (2013) S. Saida et al. BLOOD
- GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia
- (2013) I. Roberts et al. BLOOD
- Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome
- (2013) Franziska Meyr et al. BRITISH JOURNAL OF HAEMATOLOGY
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study
- (2013) M. Blink et al. HAEMATOLOGICA
- Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation
- (2013) Andrew J. Woo et al. JOURNAL OF CLINICAL INVESTIGATION
- An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
- (2013) C J Harrison et al. LEUKEMIA
- The landscape of somatic mutations in Down syndrome–related myeloid disorders
- (2013) Kenichi Yoshida et al. NATURE GENETICS
- Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome
- (2012) T. Taga et al. BLOOD
- Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971
- (2012) April D. Sorrell et al. CANCER
- Cancer cells preferentially lose small chromosomes
- (2012) Pascal H.G. Duijf et al. INTERNATIONAL JOURNAL OF CANCER
- Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
- (2012) Sébastien Malinge et al. JOURNAL OF CLINICAL INVESTIGATION
- Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
- (2012) A. Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia
- (2012) C. L. Carmichael et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells
- (2012) S. T. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells
- (2012) G. A. MacLean et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defective Hematopoietic Stem Cell and Lymphoid Progenitor Development in the Ts65Dn Mouse Model of Down Syndrome: Potential Role of Oxidative Stress
- (2011) Laureanne Pilar E. Lorenzo et al. ANTIOXIDANTS & REDOX SIGNALING
- Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia
- (2011) K. A. Alford et al. BLOOD
- Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
- (2011) A. S. Gamis et al. BLOOD
- Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia
- (2011) V. Rand et al. BLOOD
- Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
- (2011) T. Klampfl et al. BLOOD
- Molecular lesions in childhood and adult acute megakaryoblastic leukaemia
- (2011) Asahito Hama et al. BRITISH JOURNAL OF HAEMATOLOGY
- Acute lymphoblastic leukaemia in children with Down syndrome: an updated review
- (2011) Kelly W. Maloney BRITISH JOURNAL OF HAEMATOLOGY
- Transient Myeloproliferative Disorder and GATA1 Mutation in Neonates With and Without Down Syndrome
- (2011) Ming-Horng Tsai et al. INDIAN JOURNAL OF PEDIATRICS
- Gain-of-function mutations ininterleukin-7 receptor-α(IL7R) in childhood acute lymphoblastic leukemias
- (2011) Chen Shochat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
- (2010) Christine J. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome
- (2010) J Chen et al. LEUKEMIA
- Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study
- (2010) Takashi Taga et al. PEDIATRIC BLOOD & CANCER
- Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia
- (2010) K. Paulsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- (2009) S. Malinge et al. BLOOD
- ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
- (2009) M. J. Stankiewicz et al. BLOOD
- Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome
- (2009) A. P. Ng et al. BLOOD
- Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
- (2009) L. Hertzberg et al. BLOOD
- Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
- (2009) L. J. Russell et al. BLOOD
- ERG Is a Megakaryocytic Oncogene
- (2009) S. Salek-Ardakani et al. CANCER RESEARCH
- Leukaemia survival trends in children with Down's syndrome in Great Britain, 1971-2000: a population-based study
- (2009) A. Shah et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
- (2009) N Gefen et al. LEUKEMIA
- Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
- (2009) Kwan-Hyuck Baek et al. NATURE
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
- (2009) Charles G Mullighan et al. NATURE GENETICS
- Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
- (2009) A. Yoda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
- (2009) J. O. Korbel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
- (2008) O. Tunstall-Pedoe et al. BLOOD
- Trisomy 21 enhances human fetal erythro-megakaryocytic development
- (2008) S. T. Chou et al. BLOOD
- Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
- (2008) J.-H. Klusmann et al. BLOOD
- Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421
- (2008) Maureen M. O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Transient Myeloproliferative Disorder in Neonates With and Without Down Syndrome
- (2008) Nataly Apollonsky et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
- (2008) Dani Bercovich et al. LANCET
- Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
- (2007) G. Kirsammer et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started